Frederick Robert W, Carey Jeffrey M, Leach Gary E
Tower Urology Institute for Continence, Los Angeles, California 90048, USA.
Urology. 2004 Oct;64(4):669-74. doi: 10.1016/j.urology.2004.04.051.
To report, from our prospective database and review of published studies (including primary reported patient series and case reports for osseous complications after transvaginal bone anchor fixation in female pelvic reconstructive surgery), our results and those from previously reported patient series to determine the incidence of osteitis pubis and osteomyelitis.
A total of 440 patients from our database of cadaveric transvaginal sling (n = 127) and cadaveric prolapse repair with sling (n = 313) procedures had at least 3 months of examination follow-up and were included in this report. We found 15 primary reported patient series involving transvaginal bone anchor fixation in published studies, for a total of 788 patients. The combined patient population of 1228 was assessed for the incidence of osteitis pubis and osteomyelitis.
Of our 440 patients included in this study, 2 developed osteitis pubis (0.45%), and none had osteomyelitis (0%). In the published studies we reviewed, no case of osteitis pubis and 1 case of osteomyelitis (1 of 788, 0.13%) were reported. One additional case of osteomyelitis with transvaginal bone anchor fixation was reported. The combined incidence of osteitis pubis was 2 (0.16%) of 1228, and the combined incidence of osteomyelitis was 1 (0.08%) of 1228.
In procedures using transvaginal bone anchor fixation in female pelvic reconstructive surgery, the combined incidence, from our experience and that reported in published studies, of osteitis pubis and osteomyelitis was 2 (0.16%) and 1 (0.08%) of 1228, respectively. The infectious osseous complication rate associated with transvaginal pubic bone anchor fixation appears to be less than that previously reported for suprapubic bone anchor placement. In our experience, when using careful surgical technique and proper prophylactic precautions, infectious osseous complications have not been encountered.
通过我们的前瞻性数据库以及对已发表研究(包括女性盆腔重建手术中经阴道骨锚固定术后骨并发症的原始报道患者系列和病例报告)的回顾,报告我们的结果以及先前报道的患者系列结果,以确定耻骨炎和骨髓炎的发生率。
我们数据库中共有440例尸体经阴道吊带手术(n = 127)和尸体吊带脱垂修复手术(n = 313)的患者接受了至少3个月的检查随访,并纳入本报告。我们在已发表的研究中发现15个涉及经阴道骨锚固定的原始报道患者系列,共计788例患者。对这1228例患者的合并人群评估耻骨炎和骨髓炎的发生率。
在本研究纳入的440例患者中,2例发生耻骨炎(0.45%),无1例发生骨髓炎(0%)。在我们回顾的已发表研究中,未报告耻骨炎病例,报告了1例骨髓炎(788例中的1例,0.13%)。另外报告了1例经阴道骨锚固定术后骨髓炎病例。耻骨炎的合并发生率为1228例中的2例(0.16%),骨髓炎的合并发生率为1228例中的1例(0.08%)。
在女性盆腔重建手术中使用经阴道骨锚固定的手术中,根据我们的经验和已发表研究报告,耻骨炎和骨髓炎的合并发生率分别为1228例中的2例(0.16%)和1例(0.08%)。与经阴道耻骨骨锚固定相关的感染性骨并发症发生率似乎低于先前报道的耻骨上骨锚置入的发生率。根据我们的经验,当采用仔细的手术技术和适当的预防措施时,未遇到感染性骨并发症。